Back
Palisade Bio Vs. Brainstorm Cell Therapeutics Industry Stock Comparison
Sell
41
PALI
Palisade Bio
Last Price:
6.36
Seasonality Move:
-12.73%
Sell
31
BCLI
Brainstorm Cell Therapeutics
Last Price:
0.55
Seasonality Move:
9.72%
Sell
41
Palisade Bio (PALI)
is a Sell
Is Palisade Bio a Buy, Sell or Hold?
- The current Palisade Bio [PALI] share price is $6.35. The Score for PALI is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
- PALI is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
31
Brainstorm Cell Therapeutics (BCLI)
is a Sell
Is Brainstorm Cell Therapeutics a Buy, Sell or Hold?
- The current Brainstorm Cell Therapeutics [BCLI] share price is $0.55. The Score for BCLI is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
- BCLI is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PALI Stock Price Chart
What is Palisade Bio's stock price today?
-
The Palisade Bio share price today is $6.35
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PALI is experiencing buying pressure, which is a positive indicator for future bullish movement.
BCLI Stock Price Chart
What is Brainstorm Cell Therapeutics's stock price today?
-
The Brainstorm Cell Therapeutics share price today is $0.55
The current trend is relatively stagnant and BCLI is experiencing slight buying pressure.
PALI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.08 | Sell |
| Relative Strength Index (14 RSI): | 56.32 | Buy |
| Chaikin Money Flow: | 359969 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.89 - 6.13) | Buy |
| Bollinger Bands (100): | (5.49 - 8.79) | Sell |
BCLI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.01 | Buy |
| Relative Strength Index (14 RSI): | 50.54 | Buy |
| Chaikin Money Flow: | 86015 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.52 - 0.66) | Sell |
| Bollinger Bands (100): | (0.24 - 0.52) | Buy |
PALI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.46 | Buy |
| 20-day SMA: | 5.48 | Buy |
| 50-day SMA: | 5.77 | Buy |
| 200-day SMA: | 10.49 | Sell |
| 8-day EMA: | 5.55 | Buy |
| 20-day EMA: | 5.5 | Buy |
| 50-day EMA: | 5.98 | Buy |
| 200-day EMA: | 25.14 | Sell |
BCLI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.53 | Buy |
| 20-day SMA: | 0.6 | Sell |
| 50-day SMA: | 0.47 | Buy |
| 200-day SMA: | 0.65 | Sell |
| 8-day EMA: | 0.54 | Buy |
| 20-day EMA: | 0.55 | Sell |
| 50-day EMA: | 0.49 | Buy |
| 200-day EMA: | 0.78 | Sell |
Palisade Bio Earnings Growth & PALI Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.55 per share, a decrease next quarter of $0.00 per share, an increase this year of $13.73 per share, and an increase next year of $3.45 per share.
Brainstorm Cell Therapeutics Earnings Growth & BCLI Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.08 per share, and a decrease next year of $0.05 per share.
Palisade Bio Technical Analysis
| Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Brainstorm Cell Therapeutics Technical Analysis
| Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||